• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Stevanato Group, Thermo Fisher to bring on-body drug delivery system to market

March 21, 2023 By Sean Whooley

Stevanato Group Thermo Fisher collaboration on-body drug delivery system (1)
[Image courtesy of Stevanato Group]
Stevanato Group (NYSE:STVN) today announced a collaboration with Thermo Fisher Scientific (NYSE:TMO) on drug delivery technology.

The partnership aims to bring a fully integrated, on-body delivery system platform for subcutaneous administration to market.

Stevanato Group said in a news release that the planned device will be semi-reusable and provide micro-precision basal doses and full-content bolus injections. The company intends for the flexible, customizable platform to administer a wide range of therapies.

With Thermo Fisher, the collaboration enables the delivery of small molecules and biologics. These include large volumes delivered subcutaneously at home. The companies believe this could improve the adherence and effectiveness of pharmacological treatments.

What Stevanato Group and Thermo Fisher bring to this collaboration

In the partnership, Stevanato Group plans to provide pre-sterilized EZ-fill cartridges as drug containment solutions and assembly equipment. Thermo Fisher is responsible for providing fill-finish and final assembly services. Together, they expect to offer pharmaceutical companies a cartridge-based, on-body delivery system.

“We are proud to be working with Thermo Fisher Scientific to bring to the market our on-body delivery system for patients,” said Steven Kaufman, VP for drug delivery systems at Stevanato Group. “Thanks to this collaboration with Thermo Fisher, Stevanato Group will be able to respond quickly to changes in customers’ needs, enabling them to scale up production according to commercial demand. The on-body delivery system increases the accessibility of in-home care and administered treatment options.”

Stevanato Group added that the system enhances its sustainability efforts. A reusable controller extends the product’s lifespan and reduces waste. Meanwhile, the disposable pod with a pre-filled, pre-loaded cartridge can reduce user error and wasted product.

“This collaboration with Stevanato Group is an example of how we are leveraging our world-class experience and reliability in fill finish and sterile development to deliver innovative solutions at scale,” said Leon Wyszkowski, president of pharma services commercial operations, Thermo Fisher Scientific. “In line with our mission to enable our customers to make the world healthier, cleaner and safer, we’ll significantly improve patients’ access and adherence to critical medicines.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceuticals, Technology Tagged With: Stevanato Group, thermofisherscientific

IN CASE YOU MISSED IT

  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Senseonics closes public offering, private placement with Abbott
  • Embecta eyes shift from insulin delivery to broader medical supplies focus
  • Medtronic earns expanded CE mark for Prevail paclitaxel-coated balloon
  • Sequel Med Tech to pair automated insulin delivery system with Abbott’s future dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS